| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:736837 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCNF mRNA | CTD | PMID:22079256 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of CCNF mRNA | CTD | PMID:18242016 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | EXP | | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCNF mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CCNF mRNA; more ... | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCNF mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CCNF mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCNF mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCNF mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCNF mRNA | CTD | PMID:15667827 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | EXP | | 6480464 | Butylated Hydroxytoluene results in increased expression of CCNF mRNA; more ... | CTD | PMID:12867420 |
| 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of CCNF mRNA | CTD | PMID:19812364 |
| 2-methylcholine | affects expression | ISO | RGD:736837 | 6480464 | beta-methylcholine affects the expression of CCNF mRNA | CTD | PMID:21179406 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | EXP | | 6480464 | Oxazolone results in increased expression of CCNF mRNA | CTD | PMID:18242016 |
| 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CCNF mRNA | CTD | PMID:19191707 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:736837 | 6480464 | decitabine results in decreased expression of CCNF mRNA | CTD | PMID:19363521 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:736837 | 6480464 | TP53 protein affects the reaction [decitabine results in decreased expression of CCNF mRNA] | CTD | PMID:19363521 |
| 5-fluorouracil | affects response to substance | ISO | RGD:736837 | 6480464 | CCNF affects the susceptibility to Fluorouracil | CTD | PMID:15067352 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:736837 | 6480464 | Tretinoin results in decreased expression of CCNF mRNA | CTD | PMID:15498508 |
| ammonium chloride | affects expression | ISO | RGD:67401 | 6480464 | Ammonium Chloride affects the expression of CCNF mRNA | CTD | PMID:16483693 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of CCNF mRNA | CTD | PMID:15120971 PMID:15122651 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of CCNF mRNA | CTD | PMID:15122651 PMID:15120971 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CCNF mRNA | CTD | PMID:19770486 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of CCNF mRNA | CTD | PMID:15674843 |
| bisphenol A | increases expression | ISO | RGD:736837 | 6480464 | bisphenol A results in increased expression of CCNF protein | CTD | PMID:21277958 |
| C60 fullerene | increases expression | ISO | RGD:67401 | 6480464 | fullerene C60 results in increased expression of CCNF mRNA | CTD | PMID:19167457 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCNF mRNA]; more ... | CTD | PMID:20230807 |
| calcitriol | decreases expression | ISO | RGD:736837 | 6480464 | Calcitriol results in decreased expression of CCNF mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:736837 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CCNF mRNA | CTD | PMID:21592394 |
| chlorpromazine | decreases expression | ISO | RGD:736837 | 6480464 | Chlorpromazine analog results in decreased expression of CCNF mRNA | CTD | PMID:15924885 |
| cobalt dichloride | decreases expression | ISO | RGD:736837 | 6480464 | cobaltous chloride results in decreased expression of CCNF mRNA | CTD | PMID:19320972 |
| copper atom | multiple interactions | ISO | RGD:736837 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CCNF mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:736837 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CCNF mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:736837 | 6480464 | Copper Sulfate results in decreased expression of CCNF mRNA | CTD | PMID:19549813 |
| coumestrol | increases expression | ISO | RGD:736837 | 6480464 | Coumestrol results in increased expression of CCNF mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:736837 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNF mRNA | CTD | PMID:19167446 |
| diarsenic trioxide | increases expression | ISO | RGD:736837 | 6480464 | arsenic trioxide results in increased expression of CCNF mRNA | CTD | PMID:17530438 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CCNF mRNA | CTD | PMID:21266533 |
| furan | increases expression | ISO | RGD:67401 | 6480464 | furan results in increased expression of CCNF mRNA | CTD | PMID:22079235 |
| hydroquinone | decreases expression | ISO | RGD:736837 | 6480464 | hydroquinone results in decreased expression of CCNF mRNA | CTD | PMID:23416264 |
| indole-3-methanol | affects expression | ISO | RGD:67401 | 6480464 | indole-3-carbinol affects the expression of CCNF mRNA | CTD | PMID:21396975 |
| lidocaine | affects expression | EXP | | 6480464 | Lidocaine affects the expression of CCNF mRNA | CTD | PMID:18931217 |
| microcystin-LR | decreases expression | EXP | | 6480464 | cyanoginosin LR results in decreased expression of CCNF mRNA | CTD | PMID:17654400 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of CCNF mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCNF mRNA] | CTD | PMID:17854601 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CCNF mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:736837 | 6480464 | Acetaminophen results in increased expression of CCNF mRNA | CTD | PMID:22230336 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of CCNF mRNA | CTD | PMID:23091169 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CCNF mRNA | CTD | PMID:18445702 |
| quercetin | decreases expression | ISO | RGD:736837 | 6480464 | Quercetin results in decreased expression of CCNF mRNA | CTD | PMID:14715546 |
| tamibarotene | decreases expression | ISO | RGD:736837 | 6480464 | Am 80 results in decreased expression of CCNF mRNA; more ... | CTD | PMID:15498508 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of CCNF mRNA | CTD | PMID:15003993 |
| testosterone | multiple interactions | ISO | RGD:736837 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CCNF mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:736837 | 6480464 | Testosterone results in decreased expression of CCNF mRNA | CTD | PMID:21592394 |
| tetrachloromethane | affects expression | ISO | RGD:67401 | 6480464 | Carbon Tetrachloride affects the expression of CCNF protein | CTD | PMID:16092975 |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCNF mRNA | CTD | PMID:18242016 |
| topotecan | affects response to substance | ISO | RGD:736837 | 6480464 | CCNF protein affects the susceptibility to Topotecan | CTD | PMID:16217747 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of CCNF mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | ISO | RGD:736837 | 6480464 | troglitazone results in decreased expression of CCNF mRNA | CTD | PMID:19140230 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CCNF mRNA | CTD | PMID:17963808 |
| vanadyl sulfate | decreases expression | ISO | RGD:736837 | 6480464 | vanadyl sulfate results in decreased expression of CCNF mRNA | CTD | PMID:16330358 |